Product NDC: | 10139-071 |
Proprietary Name: | Ampicillin and Sulbactam |
Non Proprietary Name: | ampicillin sodium and sulbactam sodium |
Active Ingredient(s): | 250; 125 mg/mL; mg/mL & nbsp; ampicillin sodium and sulbactam sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10139-071 |
Labeler Name: | GeneraMedix Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065316 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110930 |
Package NDC: | 10139-071-10 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (10139-071-10) > 8 mL in 1 VIAL, GLASS (10139-071-18) |
NDC Code | 10139-071-10 |
Proprietary Name | Ampicillin and Sulbactam |
Package Description | 10 VIAL, GLASS in 1 CARTON (10139-071-10) > 8 mL in 1 VIAL, GLASS (10139-071-18) |
Product NDC | 10139-071 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ampicillin sodium and sulbactam sodium |
Dosage Form Name | INJECTION, POWDER, FOR SUSPENSION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110930 |
Marketing Category Name | ANDA |
Labeler Name | GeneraMedix Inc. |
Substance Name | AMPICILLIN SODIUM; SULBACTAM SODIUM |
Strength Number | 250; 125 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC] |